The 4 points where rare disease launches break down
In rare disease launches, every specialist interaction matters. Yet many organizations unintentionally create friction through misaligned priorities,…
Most pharma launches fail not because the science is wrong, but because the people delivering it are telling different stories. This one-pager shows you exactly what breaks when medical and commercial never share a room before launch day.
In rare disease launches, every specialist interaction matters. Yet many organizations unintentionally create friction through misaligned priorities,…
When launch budgets shrink, training priorities become even more important. This one-pager outlines a practical framework for…
Most pharma launches fail not because the science is wrong, but because the people delivering it are…
Rare disease launches place extraordinary demands on the field. Medical, commercial, and market access teams are often…